The Scientist

» drug development and disease/medicine

Most Recent

image: Piece by Piece

Piece by Piece

By | June 1, 2013

A guide to fragment-based drug discovery

1 Comment

image: The Next Big One

The Next Big One

By | June 1, 2013

As new infections surface and spread, science meets the challenges with ingenuity and adaptation.

2 Comments

image: Factoring in Face Time

Factoring in Face Time

By | June 1, 2013

How the study of human social interactions is helping researchers understand the spread of diseases like influenza and HIV

0 Comments

image: It Takes a Village

It Takes a Village

By | June 1, 2013

Scientists working in developing countries find that giving back to local communities enriches their own research.

3 Comments

image: Week in Review: May 27–30

Week in Review: May 27–30

By | May 31, 2013

The mosquito’s role in malaria virulence; the value of grant review; Europe must embrace GM crops; why roaches avoid sugary bait

0 Comments

image: Modified Toxin to Treat Obesity?

Modified Toxin to Treat Obesity?

By | May 29, 2013

Researchers show that a synthetic peptide derived from a sea anemone toxin has potent weight-regulating effects in a mouse model of obesity.  

0 Comments

image: BPA Dangers in Pregnancy?

BPA Dangers in Pregnancy?

By | May 28, 2013

Pregnant mice exposed to the chemical used in many plastics have offspring with behavioral abnormalities.

0 Comments

image: Inhibit Mitochondria to Live Longer?

Inhibit Mitochondria to Live Longer?

By | May 22, 2013

Researchers find that reducing mitochondrial protein production in some animals can increase lifespan by activating a protective stress response.

3 Comments

image: Vitamin C Slays TB Bacteria

Vitamin C Slays TB Bacteria

By | May 21, 2013

The essential nutrient can kill drug-resistant Mycobacterium tuberculosis by producing oxidative radicals that damage DNA.

1 Comment

image: Nano-vehicles for Cancer Drugs

Nano-vehicles for Cancer Drugs

By | May 20, 2013

Experimental cancer therapeutics delivered to tumors via nanoparticles could provide a safer and more effective therapy than conventional chemotherapy.

1 Comment

Popular Now

  1. Consilience, Episode 3: Cancer, Obscured
  2. RNAi’s Future in Drug-Target Screening
    News Analysis RNAi’s Future in Drug-Target Screening

    A recent CRISPR study contradicted years of RNA interference research on a well-studied cancer drug target. But is it the last nail in the coffin for RNAi as a screening tool? 

  3. A History of Screening for Natural Products to Fight Cancer
  4. Streakers, Poopers, and Performers: The Wilder Side of Wildlife Cameras
AAAS